Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.

Toshihiro Murata, Minoru Haisa, Hirokazu Uetsuka, Tetuji Nobuhisa, Takaomi Ookawa, Yoko Tabuchi, Yasuaki Shirakawa, Tomoki Yamatsuji, Junji Matsuoka, Masahiko Nishiyama, Noriaki Tanaka, Yoshio Naomoto

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

It is important to clarify the mechanism of resistance to cisplatin for the treatment of solid tumors. We have examined the expression of apoptosis-related proteins, Bax and Bcl-2, in ovarian cancer cells. We used the cell line 2008 and its cisplatin resistant subclone 2008 C-13. The percentage of 2008 cells showing apoptosis was significantly higher following cisplatin treatment as compared to untreated controls. 2008 C-13 cells showing apoptosis did not differ between the cisplatin-treated group and the untreated group. The expression of mRNA and protein of Bax in the two cell lines were not altered by treatment with cisplatin. Although the expression of mRNA and protein of Bcl-2 decreased in 2008 cells after treatment with cisplatin, the expression of Bcl-2 remained unchanged in 2008 C-13 cells. Our results indicate that the down-regulation of Bcl-2 plays an important role in the mechanisms of tumor resistance to anticancer drugs.

Original languageEnglish
Pages (from-to)865-868
Number of pages4
JournalInternational journal of molecular medicine
Volume13
Issue number6
Publication statusPublished - Jun 2004

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.'. Together they form a unique fingerprint.

  • Cite this

    Murata, T., Haisa, M., Uetsuka, H., Nobuhisa, T., Ookawa, T., Tabuchi, Y., Shirakawa, Y., Yamatsuji, T., Matsuoka, J., Nishiyama, M., Tanaka, N., & Naomoto, Y. (2004). Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines. International journal of molecular medicine, 13(6), 865-868.